ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2013

Apr 1, 2013

SEC Form 4/A — Form 4/A

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2013-03-21

Reporting Person: GIVEN DOUGLAS B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-21	Stock Option	$2.19	A	20000	Acquired	2023-03-21	Common Stock (20000)	Direct

Footnotes

F1: Option vests one year from date of grant.